News/SEC filing/Feb 20, 2026, 4:02 PM ET

Moderna files annual report (10-K) for the period ended Dec 31, 2025

ModernaMRNA

Moderna filed its annual report on Form 10-K with the SEC on Feb 20, 2026, 4:02 PM ET, covering the fiscal year ended Dec 31, 2025.

  • Fiscal 2025 revenue: $1.94B
  • Fiscal 2025 net income: −$2.82B
  • Fiscal 2025 diluted EPS: $-7.26
  • Form 10-K accepted by EDGAR Feb 20, 2026, 4:02 PM ET
  • Accession number 0001682852-26-000033
Source
SEC EDGAR
Feb 20, 2026, 4:02 PM ET
Read the original ↗

SEC filing 10-K · accession 0001682852-26-000033 · sec.gov ↗